Is AZN or SYK cheaper?

On trailing earnings, AZN is cheaper: AZN trades at a 12.92 P/E and SYK at 38.17.

Which has grown faster, AZN or SYK?

Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus SYK at 11.42%.

Does AZN or SYK pay a bigger dividend?

AZN yields 2.53% and SYK yields 1.07% based on trailing dividends and the latest price.

Is AZN or SYK more profitable?

AZN runs the higher net margin — AZN at 17.19% versus SYK at 13.21%.

Which has been the better investment, AZN or SYK?

Over the past 10-year, AZN delivered the higher annualized total return — AZN at 14.53% versus SYK at 11.65%. Past performance doesn't predict future results.

AstraZeneca PLC (AZN) vs Stryker Corporation (SYK)

AZN leads on 17 of 17 compared metrics.

A side-by-side comparison of AstraZeneca PLC and Stryker Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 12, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — AZN vs SYK

growth of $100 · last 30y

AZN +658.3%SYK +5726.5%SYK compounded faster

Log scale — wide-divergence pair

AZN SYK

AZN vs SYK: by the numbers

•AZN is the larger company ($133.07B vs $126.42B market cap).
•AZN trades at the lower earnings multiple (12.92 vs 38.17 P/E).
•AZN converts more revenue to profit (17.19% vs 13.21% net margin).
•AZN grew revenue faster over the past five years (16.99% vs 11.42% CAGR).
•AZN pays the higher dividend yield (2.53% vs 1.07%).

Which is better, AZN or SYK?

Metric tally: AZN 17 · SYK 0

It depends on what you're optimizing for:

ValueAZN(lower P/E)

GrowthAZN(faster 5Y revenue CAGR)

IncomeAZN(higher dividend yield)

QualityAZN(higher ROIC)

Metrics side by side

Valuation

Metric	AZN	SYK
P/E ratio	12.92●	38.17
Forward P/E	16.75●	22.01
P/S ratio	2.22●	5.04
P/B ratio	2.83●	5.55
PEG ratio	0.29●	5.16
EV / EBITDA	7.96●	21.06
FCF yield	6.02%●	3.59%

Profitability

Metric	AZN	SYK
Gross margin	81.68%●	63.67%
Operating margin	23.69%●	21.34%
Net margin	17.19%●	13.21%
ROE	21.95%●	14.52%
ROIC	13.03%●	8.53%

Dividends

Metric	AZN	SYK
Dividend yield	2.53%●	1.07%
Payout ratio	32.88%	41.46%

Growth (annualized)

Metric	AZN	SYK
Revenue CAGR (5Y)	16.99%●	11.42%
EPS CAGR (5Y)	22.02%●	14.79%
FCF CAGR (5Y)	15.68%●	11.01%
Total return CAGR (5Y)	9.97%●	5.60%

Frequently asked

Which is better, AZN or SYK?: It depends on your goal. value: AZN (lower P/E); growth: AZN (faster 5Y revenue CAGR); income: AZN (higher dividend yield); quality: AZN (higher ROIC). Across all compared metrics, AZN leads 17 to 0.
Is AZN or SYK cheaper?: On trailing earnings, AZN is cheaper: AZN trades at a 12.92 P/E and SYK at 38.17.
Which has grown faster, AZN or SYK?: Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus SYK at 11.42%.
Does AZN or SYK pay a bigger dividend?: AZN yields 2.53% and SYK yields 1.07% based on trailing dividends and the latest price.
Is AZN or SYK more profitable?: AZN runs the higher net margin — AZN at 17.19% versus SYK at 13.21%.
Which has been the better investment, AZN or SYK?: Over the past 10-year, AZN delivered the higher annualized total return — AZN at 14.53% versus SYK at 11.65%. Past performance doesn't predict future results.

Go deeper

Full AZN analysis Full SYK analysis Interactive comparison tool

Dig into the metrics

AstraZeneca P/E ratio Stryker P/E ratio AstraZeneca dividend yield Stryker dividend yield AstraZeneca ROE Stryker ROE AstraZeneca operating margin Stryker operating margin AstraZeneca revenue growth Stryker revenue growth AstraZeneca free cash flow Stryker free cash flow

AstraZeneca & Stryker appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest FCF Yield Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 12, 2026.